Facebook
TwitterAccording to a report by Q&Me, as of March 2023, Long Chau was the leading drug store chain in Vietnam with one ***** stores, followed by Pharmacity with *** stores. In that year, Vietnam had almost ***** drug stores, indicating a ** percent increase compared to the number of stores in 2022.
Facebook
Twitterhttps://www.techsciresearch.com/privacy-policy.aspxhttps://www.techsciresearch.com/privacy-policy.aspx
Vietnam Over-the-Counter (OTC) Drugs Market was valued at USD 2.11 Million in 2023 and is expected to reach USD 2.92 Million by 2029 with a CAGR of 5.50% during the forecast period.
| Pages | 82 |
| Market Size | 2023: USD 2.11 Million |
| Forecast Market Size | 2029: USD 2.92 Million |
| CAGR | 2024-2029: 5.50% |
| Fastest Growing Segment | Cough, Cold, and Flu Products |
| Largest Market | South Vietnam |
| Key Players | 1.Bayer Vietnam Ltd. 2.GSK Pharma Viet Nam Company Limited 3.Sanofi Vietnam 4.Johnson & Johnson Services, Inc. 5.GLENMARK PHARMACEUTICALS LTD. 6.Perrigo Company plc 7.Pfizer Inc |
Facebook
Twitterhttps://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
The Vietnam Diabetes Care Devices Market Report is Segmented by Device Type (Monitoring, Management), Patient Type (Type-1, Type-2, Gestational & Others), End-User (Hospitals & Clinics, Home-Care, Ambulatory Surgical Centres), Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Online Pharmacies, Direct-To-Consumer E-Commerce), and Geography (Vietnam). The Market Forecasts are Provided in Terms of Value (USD).
Facebook
Twitterhttps://www.verifiedmarketresearch.com/privacy-policy/https://www.verifiedmarketresearch.com/privacy-policy/
Vietnam Diabetes Care Drugs Market size was valued at USD 0.21 Billion in 2024 and is expected to reach USD 0.29 Billion by 2032, growing at a CAGR of 4.1% from 2025 to 2032. The Vietnam diabetes care drugs market is driven by the rising prevalence of diabetes due to changing lifestyles, unhealthy diets, and increasing obesity rates. Rapid urbanization and a growing elderly population further contribute to the rising disease burden, boosting the demand for effective diabetes medications. Additionally, heightened awareness, early diagnosis, and government initiatives supporting diabetes management fuel market growth. Advancements in pharmaceutical research and the introduction of innovative drugs, including GLP-1 receptor agonists and SGLT-2 inhibitors, are expanding treatment options. Increasing healthcare investments, improved access to insulin, and a growing preference for modern therapies over traditional treatments also drive market expansion.
Facebook
Twitterhttps://www.zionmarketresearch.com/privacy-policyhttps://www.zionmarketresearch.com/privacy-policy
La taille du marché mondial des produits de soins de la peau au Vietnam était évaluée à 860.4 millions de dollars en 2022 et devrait atteindre 1 920,7 millions de dollars d'ici 2030, à un TCAC de 10.56 %.
Facebook
Twitterhttps://www.futuremarketinsights.com/privacy-policyhttps://www.futuremarketinsights.com/privacy-policy
According to Future Market Insights’ latest research, the ASEAN aromatherapy industry value is forecast to double over the next ten years- from US$ 575.1 million in 2024 to US$ 1,127.5 million by 2034. Demand for aromatherapy products in ASEAN will probably increase at 7.2% CAGR throughout the assessment period.
| Attributes | Key Insights |
|---|---|
| Base Value in 2023 | US$ 530.8 million |
| ASEAN Aromatherapy Industry Size in 2024 | US$ 575.1 million |
| Industry Value in 2034 | US$ 1,127.5 million |
| Value CAGR (2024 to 2034) | 7.2% |
Country-wise Insights
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| Malaysia | 7.9% |
| Thailand | 7.4% |
| Indonesia | 6.4% |
| Vietnam | 7.1% |
| Philippines | 6.8% |
| Rest of ASEAN | 8.7% |
Category-wise Insights
| Product | Value CAGR (2024 to 2034) |
|---|---|
| Aromas | 7.3% |
| Equipment | 6.5% |
| Mode of Delivery | Value CAGR (2024 to 2034) |
|---|---|
| Inhalation | 8.4% |
| Topical | 6.4% |
| Aerial | 7.5% |
| Environmental | 7.7% |
| Application | Value CAGR (2024 to 2034) |
|---|---|
| Relaxation/Stress Relieving | 6.0% |
| Insomnia | 7.4% |
| Nausea | 8.7% |
| Pain Management | 5.5% |
| Scar Management | 6.7% |
| Skin & Hair Care | 4.9% |
| Cold & Cough | 9.9% |
| Sleep Management | 8.2% |
| Psychological Disease | 11.0% |
| Others | 9.4% |
| Sales Channel | Value CAGR (2024 to 2034) |
|---|---|
| Retail Pharmacy Chains | 7.7% |
| Drug Stores | 7.0% |
| Online Sales/E-commerce | 7.6% |
| Hypermarket & Supermarket | 8.9% |
| Direct Sales | 6.5% |
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Facebook
TwitterAccording to a report by Q&Me, as of March 2023, Long Chau was the leading drug store chain in Vietnam with one ***** stores, followed by Pharmacity with *** stores. In that year, Vietnam had almost ***** drug stores, indicating a ** percent increase compared to the number of stores in 2022.